Eosinophilic fasciitis (EF), or Shulman syndrome, first described in 1974, is a rare fibrosing disorder characterized by painful, symmetric swelling and progressive woody induration of skin and subcutaneous tissues. Although the pathogenesis remains unclear, EF is considered immune-mediated, often triggered by physical exertion, infections, or medications. Pediatric EF, a particularly uncommon subset, can exhibit distinct clinical features, including pronounced extracutaneous manifestations, unpredictable disease progression, and variable therapeutic responses. Clinical presentations range from rapidly advancing fibrosis leading to joint contractures to fluctuating inflammatory episodes. Diagnosis is challenging because of the absence of universal criteria, although peripheral eosinophilia, elevated inflammatory markers, and imaging findings support clinical suspicion. Definitive diagnosis depends on deep skin and fascial biopsy, revealing eosinophil-rich lymphoplasmacytic infiltrates and fibrosis. Management primarily relies on systemic corticosteroids, supplemented by steroid-sparing immunosuppressive medications in refractory cases. Early diagnosis and treatment are critical because untreated EF can cause irreversible fibrosis and significant functional impairment. The disease’s rarity, heterogeneous presentations, and unclear etiology further complicate clinical management. Recent insights suggest EF may involve intricate interactions among environmental triggers, immune dysregulation, and fibrotic remodeling. This review aims to provide an updated overview of pediatric EF, highlighting current knowledge on clinical manifestations, diagnosis, differential diagnosis, therapeutic approaches, and outcomes, supported by an illustrative case, with emphasis on areas needing further research.
The American Academy of Pediatrics (AAP) is the leading professional organization dedicated to promoting the health and well-being of infants, children, adolescents, and young adults. As a trusted authority in pediatric healthcare, the AAP serves as a valuable resource for pediatricians, parents, and caregivers.
Through its extensive publishing program, the AAP provides authoritative and up-to-date information on various aspects of child health and development. This includes peer-reviewed scientific journals like Pediatrics, consumer-focused books and magazines, and online platforms such as HealthyChildren.org, which offers evidence-based parenting advice backed by pediatricians.
The AAP's content covers a wide range of topics related to scientific research, healthcare practices, pharmaceutical developments, and general health and well-being concerns specific to children and families. Its publications feature data-driven insights, expert commentary, industry-specific analysis, reviews, and press releases, ensuring comprehensive coverage of the latest developments in pediatric medicine.
In addition to its print and digital publications, the AAP maintains an active online presence, including websites, social media channels, and video content, providing multiple avenues for disseminating vital information to its diverse audience of healthcare professionals, parents, and caregivers.
As the nation's leading advocate for children's health, the AAP plays a crucial role in shaping policies, promoting best practices, and educating the public on issues that impact the overall well-being of children and families.












